CollPlant Biotechnologies (CLGN) Operating Leases (2019 - 2025)

CollPlant Biotechnologies' Operating Leases history runs 7 years deep, the most recent figure standing at $2.0 million for Q4 2025.

• Quarterly Operating Leases fell 10.68% year-over-year to $2.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.0 million (down 10.68% YoY) and the FY2025 annual result came in at $2.0 million, down 10.68% from the prior year.
• Operating Leases was $2.0 million for Q4 2025 at CollPlant Biotechnologies, down from $2.2 million in the prior quarter.
• Across five years, Operating Leases topped out at $3.1 million in Q4 2021 and bottomed at $2.0 million in Q4 2025.
• A 5-year average of $2.5 million and a median of $2.5 million in 2023 frame the typical range for Operating Leases.
• Peak annual rise in Operating Leases reached 11.77% in 2022, while the deepest fall reached 22.89% in 2022.
• CollPlant Biotechnologies' Operating Leases stood at $3.1 million in 2021, then retreated by 22.89% to $2.4 million in 2022, then climbed by 6.42% to $2.5 million in 2023, then declined by 10.26% to $2.3 million in 2024, then dropped by 10.68% to $2.0 million in 2025.
• Business Quant data shows CLGN's Operating Leases at $2.0 million in Q4 2025, $2.2 million in Q3 2025, and $2.2 million in Q2 2025.